A new study has identified retinal imaging as a tool that can distinguish cases of abusive brain trauma with 93% accuracy.
FDA approves increased amifampridine maximum daily dose to treat Lambert-Eaton myasthenic syndrome
The maximum daily dose has increased from 80 mg to 100 mg.
PODCAST: Auditory brain stem implants in young children.
Jamie Glater, MD, discusses an NIH-sponsored study investigating the effectiveness of an auditory brain stem implant in young children with congenital cochlear nerve agenesis.
FDA approves diazepam for seizure clusters in patients 2 to 5 years
With the approval comes the immediate availability of 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses for patients between 2 to 5 years of age.
FDA approves givinostat for Duchenne muscular dystrophy in patients 6 years and up
The decision makes givinostat the first nonsteroidal drug approved to treat patients with all genetic variants of DMD.
Physical activity offers mental health boost for children with neurodevelopmental disorders
The approach can improve mental health and various subgroups such as cognitive function, psychological well-being, and more.
More options and new technology for treating epilepsy and seizures
William Gallentine, DO, explains why he is excited for the year ahead when it comes to epilepsy treatment as new technologies emerge and the treatment landscape changes.